Habib Nehmé: The U.S. Market Remains Elekta’s Most Strategic and Significant One
Habib Nehmé, Chief Commercial Officer of Elekta, shared a post on LinkedIn:
“Just completed an intensive and inspiring week visiting the United States, meeting with Elekta customers, key opinion leaders in radiotherapy and cancer care, and our energized, professional, and dedicated colleagues across Elekta U.S.
This journey took me from Washington D.C. to Philadelphia and Atlanta, offering invaluable insights into the evolving needs of the U.S. market – a market that remains Elekta’s most strategic and significant, especially in a time of global economic, political, and geopolitical uncertainty. Our focus on the United States is stronger than ever.
Elekta’s commitment to advancing radiotherapy and cancer treatment is unwavering. We actively engage with policymakers, influencers, and leaders in the academic and clinical sectors to help shape healthcare policy, reimbursement models, and technological solutions that benefit clinicians, investors, and – most importantly – patients.
Our U.S. organization, which develops (Software), sells, installs services, and supports precision radiotherapy solutions, is fully equipped and more ready than ever to meet the needs of this critical market. The breadth, innovation, and diversity of our offering are unmatched, especially now.
A heartfelt thank you to the Elekta U.S. team and leadership, Adrianus Ermers and Javier Pastor, and to our customers and partners for your trust, collaboration, and vision. Together, we are shaping the future of cancer care.”
More posts featuring Habib Nehmé.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023